Fu Haiyan, Hu Zhansheng, Di Xingwei, Zhang Qiuhong, Zhou Rongbin, Du Hongyang
Intensive Care Unit in the first affiliated hospital of Jinzhou Medical University, Jinzhou, 121000 Liaoning, China; Department of Dermatology, Beijing Children's Hospital, Capital Medical University, Beijing, 100045, China.
Intensive Care Unit in the first affiliated hospital of Jinzhou Medical University, Jinzhou, 121000 Liaoning, China.
Eur J Pharmacol. 2016 Nov 15;791:229-234. doi: 10.1016/j.ejphar.2016.08.013. Epub 2016 Aug 18.
Tenuigenin (TNG) has been reported to have various pharmacological activities, such as anti-oxidative and anti-inflammatory activities. However, the protective effects of TNG on lipopolysaccharides (LPS)-induced acute kidney injury (AKI) are still not clear. The aim of this study was to investigate the protective effects and mechanism of TGN on LPS-induced AKI in mice. The kidney histological change, levels of blood urea nitrogen (BUN), and creatinine were measured to assess the protective effects of TNG on LPS-induced AKI. The levels of TNF-α, IL-1β, and IL-6 in serum and kidney tissues were detected by ELISA. The extent of nuclear factor kappa-B (NF-κB) p65 and the expression of Toll-like receptor-4 (TLR4) were detected by western blot analysis. The results showed that TNG markedly attenuated the histological alterations, BUN and creatinine levels in kidney. TNG also suppressed LPS-induced TNF-α, IL-1β, and IL-6 production. Furthermore, the expression of TLR4 and NF-κB activation induced by LPS were markedly inhibited by TNG. In conclusion, this study demonstrated that TNG protected against LPS-induced AKI by inhibiting TLR4/NF-κB signaling pathway.
Eur Rev Med Pharmacol Sci. 2019-6
Psychopharmacology (Berl). 2025-4-26
Front Pharmacol. 2024-5-30
Am J Transl Res. 2021-4-15
Int J Mol Sci. 2020-10-9